The FDA has approved InSightec's ExAblate MRI guided focused ultrasound for treatment of painful bone metastases in patients who are not candidates for or refuse to undergo radiation treatment.

CHICAGO—The Centers for Medicare & Medicaid Services (CMS) haS designated the screening mammography recall rate a performance measure for radiology. Results of a study presented at the annual meeting of the Radiological Society of North America (RSNA) suggested the practice site is one of the factors that can impact the recall rate, and the authors suggested practice setting be considered when the recall rate is used as a quality measure.

CHICAGO—The U.S. Preventive Services Task Force (USPSTF) recommendations on mammography screening had a chilling effect on the willingness of women to get screened, David C. Levin, MD, of Thomas Jefferson University in Philadelphia, said during a presentation at the Radiological Society of North America (RSNA) on Nov. 27.

CHICAGO—Researchers have identified a biomarker that may predict patient prognosis after a mild traumatic brain injury (MTBI), or concussion, according to a study presented Nov. 26 at the annual meeting of the Radiological Society of North America (RSNA).

CHICAGO—When an audience member asked why PET/CT is not already included in the clinical oncologic guidelines for the management of locally advanced breast cancer, two expert panelists at the annual Radiological Society of North America (RSNA) meeting explained that the push for conclusive, evidence-based medicine may be one consideration.

RSNA is a chance for those in the radiology community to meet, swap stories and share information about the latest developments in imaging. In that spirit, Health Imaging will be talking to people at the meeting each day and asking them each one question. We’ll share a few responses each day, so be sure to keep an eye out for our newsletter or check the RSNA section of our website.Today’s question: With the show just kicking off, what are you most interested in seeing at this year’s RSNA?

CHICAGO—A mock jury trial that reconstructed the hypothetical malpractice case of a 35-year old woman who died of breast cancer after five CT exams and a CT coronary angiogram in 1998-2000 ended with a split decision on Nov. 25. Nevertheless, the proceedings achieved their purpose, Leonard Berlin, MD, of NorthShore University Health System in Chicago, told Health Imaging.

The addition of screening breast tomosynthesis to digital mammography increased diagnostic accuracy and reduced recall rates, according to a study published online Nov. 21 in Radiology.